Cargando…
N(6)-methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma
N(6)-methyladenosine (m6A) RNA methylation is the most prevalent type of mRNA modification; however, little is known about its function in clear cell renal cell carcinoma (ccRCC). The present study aimed to establish and validate a m6A-related risk signature as a prognostic factor for patients with...
Autores principales: | Zheng, Zongtai, Mao, Shiyu, Guo, Yadong, Zhang, Wentao, Liu, Ji, Li, Cheng, Yao, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108075/ https://www.ncbi.nlm.nih.gov/pubmed/32323803 http://dx.doi.org/10.3892/or.2020.7524 |
Ejemplares similares
-
Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2020) -
Recent Trends in the Incidence of Clear Cell Adenocarcinoma and Survival Outcomes: A SEER Analysis
por: Guo, Yadong, et al.
Publicado: (2022) -
N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma
por: Liu, Wei, et al.
Publicado: (2020) -
A Genomic-Clinicopathologic Nomogram for the Prediction of Lymph Node Invasion in Prostate Cancer
por: Zheng, Zongtai, et al.
Publicado: (2021) -
Immunological perspective on the malignant progression of renal clear cell carcinoma
por: Liu, Ji, et al.
Publicado: (2021)